Carbonic Anhydrase Inhibitor [EPC]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Carbonic Anhydrase Inhibitor [EPC] includes 4 drugs with a combined 12,138 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
12,138
Combined Reports
All Carbonic Anhydrase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| BRINZOLAMIDE | BRINZOLAMIDE | 3,985 | 298 | 260 | 7.5% |
| DORZOLAMIDE | DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE | 3,814 | 8 | 144 | 0.2% |
| ACETAZOLAMIDE | Acetazolamide | 2,743 | 224 | 1,021 | 8.2% |
| DICHLORPHENAMIDE | Dichlorphenamide | 1,596 | 13 | 229 | 0.8% |
Common Side Effects in Carbonic Anhydrase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Treatment failure | 3,329 | 0 |
| Drug ineffective | 1,276 | 17 |
| Off label use | 634 | 42 |
| Fatigue | 568 | 175 |
| Dizziness | 562 | 196 |
| Dyspnoea | 542 | 213 |
| Hypersensitivity | 511 | 1 |
| Headache | 500 | 177 |
| Eye pain | 499 | 199 |
| Eye irritation | 461 | 0 |